FIFTH EXTENSION - GRANTED
granted
on 02 Jul 2024
Last Applicant/ Owned by
30-02 48TH AVENUE
LONG ISLAND CITY
NY
11101
Serial Number
90309237 filed on 10th Nov 2020
Registration Number
N/A
Correspondent Address
Rachelle A. Dubow, Esq.
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
Disclaimer
NO DATA
RENBIO
Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, pulse and waveform generators for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and wave Read More
Classification Information
Class [010]
Medical Instrument Products
Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, pulse and waveform generators for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices comprised of pulse and waveform generators using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices comprised of pulse and waveform generators for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical preparations for gene delivery pharmaceuticals for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Biological preparations for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Biological products, namely, DNA circle, DNA primers, linear DNA and buffers for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; Biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90309237
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 111846-0002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Sep 2024 | CORRECTED NOA E-MAILED |
| 02th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 02th Jul 2024 | SOU EXTENSION 5 FILED |
| 02th Jul 2024 | SOU EXTENSION 5 GRANTED |
| 28th Jun 2024 | DIVISIONAL REQUEST RECEIVED |
| 28th Jun 2024 | DIVISIONAL PROCESSING COMPLETE |
| 27th Jun 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Jun 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 12th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |